Roger Tell

Roger Tell, MD, PhD, currently serves as Chief Medical Officer and Chief Executive Officer at Isofol Medical AB and has held multiple senior roles, including Senior Vice President of Clinical Development and Chief Scientific Officer at the same company. As the Founder and CEO of Tell Oncology Consulting AB since April 2023, Roger Tell provides support to pharmaceutical and biotech firms in drug development. Roger holds board memberships at Vivesto and One-carbon Therapeutics AB, along with a mentorship role at the Nordic Mentor Network for Entrepreneurship. Roger has also served as an Assistant Professor at Karolinska Institutet and has held various positions in clinical development and project management within the oncology field at companies such as APREA Therapeutics AB, Servier, and Merck Group. Education credentials include a PhD in Experimental Oncology and an MD from Karolinska Institutet.